FibroGen (FGEN) Stock: Buy, Sell, or Hold?
$9.71
+0.69 (+7.65%)
â˛
5d:
+11.61%
30d:
+16.57%
90d:
-12.29%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (87%)
Quality Score
43/100
Position
FAIR
Forward P/E & Valuation
-0.8x
Next 12M consensus est.
Wall Street Target
$43.00
+342.8% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$8.36 / $9.75
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: FGEN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When FGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: FGEN is currently trading at $9.71, which is considered fair based on recent price action.
Technical Outlook: Technically, FGEN is in a strong downtrend. The price is approaching resistance at $9.75. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.6% recently.
Market Sentiment: FGEN scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $43.00 (+342.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FGEN is in a strong downtrend. The price is approaching resistance at $9.75. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.6% recently.
Market Sentiment: FGEN scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $43.00 (+342.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
43/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
86.8%
Trading Range & Key Levels
Support Level
$8.36
Resistance Level
$9.75
Current Trend
Strong Downtrend
Technical data as of
Jan 7, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+7.6%)
- BULLISH: Trading 342.8% below Wall St target ($43.00)
- WARNING: Composite score 43/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.81
Wall Street Target
$43.00
(+342.8%)
Revenue Growth (YoY)
774.8%
Earnings Growth (YoY)
53.6%
Profit Margin
2598.9%
Share FGEN Analysis
Share this live FGEN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (FGEN)
Bearish
9 Retail Mentions
Reddit / WSB Comments
8
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Dec 17, 2025
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits message suggests optimism towards $FGEN's performance, despite the lack of recent news articles.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 6:08 PM ET
Data refreshes hourly during market hours. Next update: 7:08 PM
Data refreshes hourly during market hours. Next update: 7:08 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
DNTH
Dianthus Therapeutics InâĻ |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 39 SELL |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$122 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive FGEN Research Pages
